|
Drug & Device Most Favored Nations Pricing Initiatives & Implementing CMS GENEROUS, GLOBE & GUARD Models Featured at the Virtual Pharmaceutical and Medical Device Pricing and Payment Transformation Summit
|
- Virtual Online Video Event Live and Archived
- Covering Tariffs, Most Favored Nation, TrumpRX, Direct to Consumer, Direct to Employer, Role of CMS & CMMI: GENEROUS, GLOBE, GUARD & BALANCE Models, IRA Medicare Drug Price Negotiations, Price Reporting, FDA Regulation, Medicaid Rebates, Medicare Fair Price, 340B and PBMs
- Media Partners: Harvard Health Policy Review, Health Affairs and Inside Health Policy
- June 16-19, 2026
- www.pharmapricingsummit.com
PRESS RELEASE
Phone: 800-503-7414
Email: reginfo@hcconferences.com
Website: www.pharmapricingsummit.com |
|
EARLY BIRD REGISTRATION
|
|
Click here to register by April 10 for early bird registration discount.
|
|
AGENDA-AT-A-GLANCE
|
|
Click here to view Agenda-at-a-Glance
|
|
PRESENTATION PROPOSALS
|
|
Click here to submit a presentation proposal.
|
|
FEATURING AN OVERVIEW OF US PHARMA & DEVICE MOST FAVORED NATIONS/INTERNATIONAL
REFERENCE PRICING INITIATIVES BY
|
Lanhee Chen, PhD
Fellow, Hoover Institution, Stanford; Former Counselor, HHS; Author, "Alternatives to Government-Imposed Price Controls to Lower US Drug Prices", Stanford, CA |
Liz Fowler, PhD, JD
Scholar, Johns Hopkins Bloomberg School of Public Health; Former Director, CMS CMMI (Biden); Former Special Assistant to President Obama, Washington, DC |
James Robinson, PhD
Schaeffer Professor of Health Economics & Director, Berkeley Center for Health Technology, University of California, Berkeley; Author, "Most Favored Nation Pricing is an Idea whose Time has Come", Berkeley, CA |
Ian Spatz, MPA, JD
Principal, Rock Creek Policy Group; Former Vice President, Public Policy, Merck, Author, "Most Favored Nation Drug Pricing: Aiming at Pharma's Achilles Heel", Washington, DC |
Kristi Martin, MA, MPH
Founder, Highway 136 Consulting; Former Chief of Staff for Medicare, CMS; Former Health Care VP, Arnold Ventures, Washington, DC (Moderator)
|
|
AND IMPLEMENTING THE CMS/CMMI BALANCE, GENEROUS, GLOBE AND GUARD MODELS BY
|
Cindy Cerneka, MBA
Managing Director, Helio Health Group; Former Manager Government Reporting and Commercial Rebates, Mallinckrodt Pharmaceuticals, Durham, NC |
Tracy Mumpower
Director Managed Services, Helio Health Group; Former Manager, Commercial Contract Administration, King Pharmaceuticals, Bristol, VA |
Joseph Skupen, CPA
Managing Director, Senior Advisor and Technical Leader, Helio Health Group; Former Director FMV Tiering Global Medical Affairs, Sanofi, Berwyn, PA |
Stephanie Trunk, JD, CPS
Partner and Life Sciences Industry Group Co-Leader, ArentFox Schiff; Former Legal Counsel, Catalyst Health Solutions, Washington, DC |
Chris Cobourn, MS
Managing Director and Government Programs (GP) Practice Lead, Helio Health Group, Placida, FL (Moderator)
|
|
WASHINGTON DC USA -- HEALTHCARE UPDATE NEWS SERVICE™ -- MARCH 27, 2026: The Virtual Pharmaceutical and Medical Device Pricing and Payment Transformation Summit will take place on June 16-19, 2026 as a purely virtual online event broadcast live and will remain available in video archive for 9 months. The Summit will cover the following matter relevant to pharmaceutical and medical device companies: Tariffs, Most Favored Nation, TrumpRX, Direct to Consumer, Direct to Employer, Role of CMS & CMMI: GENEROUS, GLOBE, GUARD & BALANCE Models, IRA Medicare Drug Price Negotiations, Price Reporting, FDA Regulation, Medicaid Rebates, Medicare Fair Price, 340B and PBMs.
|
|
FEATURED FACULTY
|
Shani Harmon Alexander, MS, JD
Senior Trade Counsel, Gilead; Former Director, Legal Manufacturing, Organon, Washington, DC |
Heather Banuelos, JD
Counsel, King & Spalding LLP; Former FDA Counsel, Allergan; Former Associate Chief Counsel, US Food and Drug Administration, Washington, DC |
Brian A. Bohnenkamp, MHA, JD
Partner, FDA and Life Sciences, King & Spalding, Washington, DC
|
Catherine Brandon, JD
Partner, Arnold & Porter; Senior Counsel, Office of the Assistant Secretary for Legislation, US Department of Health and Human Services, Washington, DC |
Marijo G. Bustos, MBA
Head of Government Pricing & Reimbursement, UCB; Former Director, Prometic BioProduction & BioTherapeutics & Fresenius-Kabi USA, Smyrna, GA |
Cindy Cerneka, MBA
Managing Director, Helio Health Group; Former Manager Government Reporting and Commercial Rebates, Mallinckrodt Pharmaceuticals, Durham, NC
|
Lanhee Chen, PhD
Fellow, Hoover Institution, Stanford; Former Counselor, HHS; Author, "Alternatives to Government-Imposed Price Controls to Lower US Drug Prices", Stanford, CA |
Chris Cobourn, MS
Managing Director and Government Programs (GP) Practice Lead, Helio Health Group, Placida, FL |
John Coster, PhD, RPh
Former Director, Division of Pharmacy, & Senior Advisor, Medicare Drug Rebate & Negotiation Program, CMS, Fort Lauderdale, FL
|
David Dopf, JD
Executive Director & Executive Counsel, US Human Pharma Business Law, Boehringer Ingelheim, Ridgefield, CT |
Liz Fowler, PhD, JD
Scholar, Johns Hopkins Bloomberg School of Public Health; Former Director, CMS CMMI (Biden); Former Special Assistant to President Obama, Washington, DC |
Galina Free, MSc
Head of Trade Compliance, Danaher; Former Global Tax and Customs, Cisco, Bellevue, WA
|
Jeffrey Handwerker, JD
Partner, Arnold & Porter; Lead Author, "HHS-OIG Guidance on Manufacturer DTC Platforms and Congressional Pushback", Washington, DC |
Erin Hertzog, JD, MPH
Partner, Manatt, Phelps & Phillips LLP; Former Attorney, Office of the General Counsel, CMS Division, US DHHS; Former Director, Health Law & Policy, Biotechnology Industry Organization, Washington, DC |
Mary Kohler, JD
Founder and Principal, Kohler Health Law, PC; Former Expert Counsel, Worldwide Compliance & Business Ethics, Amgen; Former Assistant General Counsel, GSK, Los Angeles, CA
|
|
|
|
EARLY BIRD REGISTRATION
|
Click here to register by April 10 for early bird registration discount.
|
|
AGENDA-AT-A-GLANCE
|
Click here to view Agenda-at-a-Glance
|
|
SPECIAL PHARMACEUTICAL COMPLIANCE FORUM (PCF) REGISTRATION DISCOUNT
|
Register by April 10 for Early Bird Discount.
PCF member companies click here to register.
|
|
PRODUCED BY
|
|
|
MEDIA PARTNERS
|
|
|
TUITION SCHOLARSHIPS
|
The Pharma Pricing Summit offers partial and full Tuition Scholarships to qualifying representatives of government, consumer advocate organizations, academics, students, representatives of health services research organizations, and those in employment transition.
Click here for more information.
|
|
Kristi Martin, MA, MPH
Founder, Highway 136 Consulting; Former Chief of Staff for Medicare, CMS; Former Health Care VP, Arnold Ventures, Washington, DC |
Rosemary Maxwell, JD
Counsel, Arnold & Porter; Coauthor, "Trump Administration Issues Executive Order to Lower Prescription Drug Costs", Washington, DC |
Roger McCrary, JD
Senior Trade Counsel, Becton Dickinson; Former Vice President of Global Compliance, Momentive; Former Global Trade Compliance Program Leader, Medtronic, Oakland, MI |
Tracy Mumpower
Director Managed Services, Helio Health Group; Former Manager, Commercial Contract Administration, King Pharmaceuticals, Bristol, VA |
William Newton
Associate Editor/Senior Writer, 340B Report; Senior Healthcare Reporter, GlobalData Healthcare, Washington, DC
|
Sayeh Nikpay, MPH, PhD
Associate Professor, School of Public Health, University of Minnesota; Lead Author, "When Safety-Net Programs Compete: Medicaid, 340B, and the Battle Over Drug Discounts", Minneapolis, MN |
Lindsay Pronley
Director Managed Services, Life Science Revenue Management, Government Pricing & Commercial Contacting, Helio Health Group, Milwaukee, WI |
Nikki Reeves, JD
Partner and Co-chair, Life Sciences and Healthcare Industry Group, King & Spalding, Washington, DC |
James Robinson, PhD
Schaeffer Professor of Health Economics & Director, Berkeley Center for Health Technology, University of California, Berkeley; Author, "Most Favored Nation Pricing is an Idea whose Time has Come", Berkeley, CA |
Avik S. A. Roy
Co-Founder & Chairman, The Foundation for Research on Equal Opportunity; Chief Strategy Officer, Strive; Former Advisor, Presidential Campaigns of Marco Rubio, Rick Perry, and Mitt Romney, Austin, TX
|
Gillian M. Russell, JD
Counsel, FDA & Life Sciences Practice, King & Spalding; Former Consultant, Corporate Executive Board, Washington, DC |
Valinda Rutledge, MBA
Executive Vice President, Policy and Advocacy, America's Physician Groups; Former Group Director, Patient Care Model Group and BPCI Lead, CMS, Washington, DC |
William Sarraille, JD
Select Counsel, Rare Access Action Project (RAAP); Facioscapulohumeral Muscular Dystrophy (FSHD) Society; and AIDS Drug Assistance Programs (ADAPs); Former Partner, Sidley Austin, Washington, DC |
John Shakow, JD
Pharmaceutical Government Price Reporting Expert; Partner, FDA & Life Sciences Practice, King & Spalding LLP, Washington, DC |
Joshua M. Sharfstein, MD
Vice Dean, Johns Hopkins Bloomberg School of Public Health; Former Secretary, Maryland's Health Department; Former Principal Deputy Commissioner, US FDA, Baltimore, MD
|
Neena Shenai, JD
Partner, WilmerHale; Former Chief Legal Counsel and Head of Compliance for Global Trade, Medtronic; Former Trade Counsel, Ways and Means Committee, US House of Representatives, Washington, DC |
Nick Shipley
Founder, Cronus Consulting; Former EVP, Biotechnology Innovation Organization (BIO); Former VP, Pharmaceutical Researchers and Manufacturers Association (PhRMA); Former Legislative Director, US House of Representatives, Washington, DC |
Joseph Skupen, CPA
Managing Director, Senior Advisor and Technical Leader, Helio Health Group; Former Director FMV Tiering Global Medical Affairs, Sanofi, Berwyn, PA |
Mariana P. Socal, MD, PhD, MPP, MSc
Associate Professor, Bloomberg School of Public Health and Carey Business School, Johns Hopkins University; Co-author, "Comparative Approaches to Drug Pricing" and "Tariffs as a Hidden Tax: Price Pass-Through in Multi-Stage Supply Chains", Baltimore, MD |
Ian Spatz, MPA, JD
Principal, Rock Creek Policy Group; Former Vice President, Public Policy, Merck, Author, "Most Favored Nation Drug Pricing: Aiming at Pharma's Achilles Heel", Washington, DC
|
Stephanie Trunk, JD, CPS
Partner and Life Sciences Industry Group Co-Leader, ArentFox Schiff; Former Legal Counsel, Catalyst Health Solutions, Washington, DC |
Arun Venkataraman, MA, JD
Partner, Covington; Former Assistant Secretary of Commerce, US and Foreign Commercial Service, International Trade Administration; Former Counselor to the Secretary, US Department of Commerce, Washington, DC |
Julie Ritchie Wagner, JD
Senior Assistant General Counsel & Head of Global Ethics, Compliance & Enforcement Legal Policy, PhRMA; Former Senior Counsel, Office of Counsel to the Inspector General, US Department of Health and Human Services, Washington, DC
|
|
FOR E-MAIL ADDRESS CHANGE, ADD OR DELETE REQUESTS:
|
|
For changes or additions, please email your request to: listmgr@HealthcareUpdateNewsService.com.
For automatic removal of your e-mail address, please click the "SafeUnsubscribe" link located in the footer of this message below.
|
|
